These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16098015)

  • 41. Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer.
    Hadley DW; Jenkins JF; Dimond E; de Carvalho M; Kirsch I; Palmer CG
    J Clin Oncol; 2004 Jan; 22(1):39-44. PubMed ID: 14701766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.
    Domingo E; Laiho P; Ollikainen M; Pinto M; Wang L; French AJ; Westra J; Frebourg T; Espín E; Armengol M; Hamelin R; Yamamoto H; Hofstra RM; Seruca R; Lindblom A; Peltomäki P; Thibodeau SN; Aaltonen LA; Schwartz S
    J Med Genet; 2004 Sep; 41(9):664-8. PubMed ID: 15342696
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact.
    Claes E; Denayer L; Evers-Kiebooms G; Boogaerts A; Legius E
    Patient Educ Couns; 2004 Nov; 55(2):265-74. PubMed ID: 15530764
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The introduction of a choice to learn pre-symptomatic DNA test results for BRCA or Lynch syndrome either face-to-face or by letter.
    Voorwinden JS; Jaspers JP; ter Beest JG; Kievit Y; Sijmons RH; Oosterwijk JC
    Clin Genet; 2012 May; 81(5):421-9. PubMed ID: 22091929
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Eur J Cancer; 2007 Jan; 43(1):71-7. PubMed ID: 17045473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Evaluation of outpatient management in HNPCC].
    Bach K; Hüppe D; Schmiegel W; Epplen JT; Kunstmann E
    Z Gastroenterol; 2005 Jul; 43(7):647-51. PubMed ID: 16001346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic testing in hereditary colorectal cancer: indications and procedures.
    Terdiman JP; Conrad PG; Sleisenger MH
    Am J Gastroenterol; 1999 Sep; 94(9):2344-56. PubMed ID: 10483990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic counseling in hereditary nonpolyposis colorectal cancer: an extended family with MSH2 mutation.
    Lynch HT; Lemon S; Smyrk T; Franklin B; Karr B; Lynch J; Slominski-Caster S; Murphy P; Connolly C
    Am J Gastroenterol; 1996 Dec; 91(12):2489-93. PubMed ID: 8946971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prevention of colorectal cancer in families with hereditary nonpolyposis colorectal cancer].
    Bernstein IT; Bisgaard ML; Myrhøj T
    Ugeskr Laeger; 2003 Jan; 165(3):221-5. PubMed ID: 12555703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Psychological consequences of predictive genetic testing: a systematic review.
    Broadstock M; Michie S; Marteau T
    Eur J Hum Genet; 2000 Oct; 8(10):731-8. PubMed ID: 11039571
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decision making and experiences of young adults undergoing presymptomatic genetic testing for familial cancer: a longitudinal grounded theory study.
    Godino L; Jackson L; Turchetti D; Hennessy C; Skirton H
    Eur J Hum Genet; 2018 Jan; 26(1):44-53. PubMed ID: 29162934
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reflex testing for Lynch syndrome: if we build it, will they come? Lessons learned from the uptake of clinical genetics services by individuals with newly diagnosed colorectal cancer (CRC).
    Tomiak E; Samson A; Spector N; Mackey M; Gilpin C; Smith E; Jonker D; Allanson J; Asmis T
    Fam Cancer; 2014 Mar; 13(1):75-82. PubMed ID: 24002367
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patient Satisfaction with Private Genetic Counselling for Familial Cancer in Western Australia: A Prospective Audit.
    Perera CN; O'Sullivan S; Pachter N; Tan JJ; Cohen PA
    Asian Pac J Cancer Prev; 2021 Oct; 22(10):3253-3259. PubMed ID: 34711002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Initiation of reflective frames in counseling for Huntingtons Disease predictive testing.
    Sarangi S; Bennert K; Howell L; Clarke A; Harper P; Gray J
    J Genet Couns; 2004 Apr; 13(2):135-55. PubMed ID: 15604629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The psychological complexity of predictive testing for late onset neurogenetic diseases and hereditary cancers: implications for multidisciplinary counselling and for genetic education.
    Evers-Kiebooms G; Welkenhuysen M; Claes E; Decruyenaere M; Denayer L
    Soc Sci Med; 2000 Sep; 51(6):831-41. PubMed ID: 10972428
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Telegenetics use in presymptomatic genetic counselling: patient evaluations on satisfaction and quality of care.
    Otten E; Birnie E; Ranchor AV; van Langen IM
    Eur J Hum Genet; 2016 Apr; 24(4):513-20. PubMed ID: 26173963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is informed choice in genetic testing a different breed of informed decision-making? A discussion paper.
    Emery J
    Health Expect; 2001 Jun; 4(2):81-6. PubMed ID: 11359537
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interactive e-counselling for genetics pre-test decisions: where are we now?
    Birch PH
    Clin Genet; 2015 Mar; 87(3):209-17. PubMed ID: 24828354
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delivery of Internet-based cancer genetic counselling services to patients' homes: a feasibility study.
    Meropol NJ; Daly MB; Vig HS; Manion FJ; Manne SL; Mazar C; Murphy C; Solarino N; Zubarev V
    J Telemed Telecare; 2011; 17(1):36-40. PubMed ID: 21097566
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Colorectal cancer in the family: psychosocial distress and social issues in the years following genetic counselling.
    Bleiker EM; Menko FH; Kluijt I; Taal BG; Gerritsma MA; Wever LD; Aaronson NK
    Hered Cancer Clin Pract; 2007 Jun; 5(2):59-66. PubMed ID: 19725985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.